Latest market price
11.37
-0.53-4.45%
OverviewShort InterestFilings
FDMTQT574D Molecular Therapeutics, Inc.·NASDAQ
11.37-4.45%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 20, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Sep 28, 20268-KCurrent report
Sep 22, 20264Statement of changes in beneficial ownership
Sep 16, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 13, 202610-QQuarterly report
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 20, 20268-KCurrent report
Jul 14, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
#1 / 25 of 327
Page
▼
/ 14